Bicycle Therapeutics plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Bicycle Therapeutics plc (BCYC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.51 million shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-11-04
- Bicycle Therapeutics plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 84.21K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2021-09-30 | 84.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.51M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 1.42M shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |